Cite
Bouras E, Karhunen V, Gill D, et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022;20(1):3doi: 10.1186/s12916-021-02193-0.
Bouras, E., Karhunen, V., Gill, D., Huang, J., Haycock, P. C., Gunter, M. J., Johansson, M., Brennan, P., Key, T., Lewis, S. J., Martin, R. M., Murphy, N., Platz, E. A., Travis, R., Yarmolinsky, J., Zuber, V., Martin, P., Katsoulis, M., Freisling, H., Nøst, T. H., Schulze, M. B., Dossus, L., Hung, R. J., Amos, C. I., Ahola-Olli, A., Palaniswamy, S., Männikkö, M., Auvinen, J., Herzig, K. H., Keinänen-Kiukaanniemi, S., Lehtimäki, T., Salomaa, V., Raitakari, O., Salmi, M., Jalkanen, S., Jarvelin, M. R., Dehghan, A., & Tsilidis, K. K. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC medicine, 20(1), 3. https://doi.org/10.1186/s12916-021-02193-0
Bouras, Emmanouil, et al. "Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis." BMC medicine vol. 20,1 (2022): 3. doi: https://doi.org/10.1186/s12916-021-02193-0
Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, Johansson M, Brennan P, Key T, Lewis SJ, Martin RM, Murphy N, Platz EA, Travis R, Yarmolinsky J, Zuber V, Martin P, Katsoulis M, Freisling H, Nøst TH, Schulze MB, Dossus L, Hung RJ, Amos CI, Ahola-Olli A, Palaniswamy S, Männikkö M, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Lehtimäki T, Salomaa V, Raitakari O, Salmi M, Jalkanen S, Jarvelin MR, Dehghan A, Tsilidis KK. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022 Jan 11;20(1):3. doi: 10.1186/s12916-021-02193-0. PMID: 35012533.
Copy
Download .nbib